<DOC>
	<DOCNO>NCT01999699</DOCNO>
	<brief_summary>This study investigate response immune system hepatitis B ( HB ) vaccine healthy adult 50 70 year age . This study partially fund National Institute Allergy Infectious Diseases .</brief_summary>
	<brief_title>A Study Immune Response Heplisav Healthy Older Adults</brief_title>
	<detailed_description>The purpose study examine immune system respond vaccination HEPLISAV .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<criteria>50 70 year age , inclusive In good health opinion principal investigator , base upon medical history physical examination Serum negative HBsAg , antiHBs , antibody hepatitis B core antigen ( antiHBc ) , hepatitis C virus ( HCV ) , human immunodeficiency virus ( HIV ) If female childbearing potential , agree consistently use highly effective method birth control screen visit Week 12/Visit 10 Pregnant , breastfeeding , plan pregnancy Known history autoimmune disease Previously receive hepatitis B vaccine ( approved investigational ) Bodymass index ( BMI ) &gt; 30 kg/m2 , diabetes mellitus ( type 1 2 ) , chronic medical condition opinion principal investigator might interfere immune response hepatitis B vaccination</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Heplisav</keyword>
</DOC>